Breastcancer.org Podcast

Beth Fairchild, president of METAvivor, talks about the #ThisIsMBC Elements Project. Running time: 56 seconds

Sheila McGlown, who was diagnosed with metastatic breast cancer 5 years after her mother died of the disease, talks about her work with the Shades of Brown Foundation to advocate for, educate, and support Black women diagnosed with breast cancer.Running time: 3:02

Brian Wojciechowski, M.D., practices medical oncology in Delaware County, Pennsylvania at Riddle, Taylor, and Crozer hospitals and also serves as Breastcancer.org's medical adviser. A native of South Philadelphia, he trained at Temple University School of Medicine and Lankenau Medical Center. Dr. Wojciechowski is a sought-after speaker on the topics of medical ethics and the biology of cancer.Listen to the podcast to hear Dr. Wojciechowski explain: the different types of white blood cells and what they do in the body how chemotherapy and targeted therapy medicines lower white blood cell counts why low white blood cell counts raise the risk of infection how doctors monitor white blood cell counts symptoms of infection to watch out for steps you can take during chemotherapy to keep your risk of infection as low as it can be Running time: 12:19

Brian Wojciechowski, M.D., practices medical oncology in Delaware County, Pennsylvania at Riddle, Taylor, and Crozer hospitals and also serves as Breastcancer.org's medical adviser. A native of South Philadelphia, he trained at Temple University School of Medicine and Lankenau Medical Center. Dr. Wojciechowski is a sought-after speaker on the topics of medical ethics and the biology of cancer. A recent study found that the number of women having 3D mammograms has increased dramatically in the last four years. Still, 3D mammograms are not available everywhere. Listen to the podcast to hear Dr. Wojciechowski explain: the difference between 2D and 3D mammograms why 3D mammograms are a standard of care, but not the standard of care how to find a center that offers 3D mammography, if you decide you would like one Running time: 11:07 Thank you for listening to the Breastcancer.org podcast. Please subscribe on iTunes, Stitcher, Spotify, TuneIn, or wherever you listen to podcasts. To share your thoughts about

Jack Goodpasture, senior director of medical affairs at Eli Lilly and Company, discusses some of the research presented at the 2019 San Antonio Breast Cancer Symposium that might be most applicable to people diagnosed with breast cancer. Running time: 5:11 Thank you for listening to the Breastcancer.org podcast. Please subscribe on iTunes, Stitcher, Spotify, TuneIn, or wherever you listen to podcasts. To share your thoughts about this or any episode, leave feedback on the podcast episode landing page on our website.

Dr. Rashmi Murthy, assistant professor of breast medical oncology at the University of Texas MD Anderson Cancer Center in Houston, discusses the results of the HER2CLIMB study that she presented at the 2019 San Antonio Breast Cancer Symposium showing that the experimental medicine tucatinib offers benefits to people diagnosed with HER2-positive metastatic breast cancer and may be a new standard of care. Listen to the episode to hear Dr. Murthy explain: a summary of the study results why this study included people with brain metastases the side effects of tucatinib why she thinks the results are practice changing Running time: 8:22 Thank you for listening to the Breastcancer.org podcast. Please subscribe on iTunes, Stitcher, Spotify, TuneIn, or wherever you listen to podcasts. To share your thoughts about this or any episode, leave feedback on the podcast episode landing page on our website.

For nearly 25 years, Kelly Grosklags has dedicated her practice to minimizing suffering through her work in oncology, palliative care and hospice. An experienced therapist, Kelly is a licensed clinical social worker and a board-certified diplomat in clinical social work. She also earned a fellowship in grief counseling from the American Academy of Health Care Professionals. Kelly speaks frequently about end-of-life issues, including care, grief and loss, both in person and on her website, Conversations With Kelly. Her passionate and supportive demeanor helps patients, caregivers and health professionals connect with the wisdom of making life more meaningful, coping with depression and anxiety, transforming fear into hope, healing versus curing, and the wisdom of dying a good death.Listen to the podcast to hear Kelly talk about: taming the feelings of fear, anger, and loss of control that can come with a metastatic diagnosis strategies to deal with “scanxiety” how to allow yourself to ask for help how and how

For nearly 25 years, Kelly Grosklags has dedicated her practice to minimizing suffering through her work in oncology, palliative care and hospice. An experienced therapist, Kelly is a licensed clinical social worker and a board-certified diplomat in clinical social work. She also earned a fellowship in grief counseling from the American Academy of Health Care Professionals and is the author of A Comforted Heart: An Oncology Psychotherapist Perspective on Finding Meaning and Hope During Illness and Loss. Kelly speaks frequently about end-of-life issues, including care, grief and loss, both in person and on her website, Conversations With Kelly. Her passionate and supportive demeanor helps patients, caregivers and health professionals connect with the wisdom of making life more meaningful, coping with depression and anxiety, transforming fear into hope, healing versus curing, and the wisdom of dying a good death. Listen to the podcast to hear Kelly talk about: what PTSD is, what causes it, and some of the most

Deven McGraw is the chief regulatory officer for Ciitizen, a tech company creating a platform that helps people collect, organize, and share their medical records digitally. Before joining Ciitizen, she directed U.S. health privacy and security policy as deputy director for health information privacy at the Department of Health and Human Services Office for Civil Rights, the office that oversees HIPAA policy and enforcement. She also served as acting chief privacy officer for the Office of the National Coordinator for Health IT. McGraw also served as an adviser to the Patient-Centered Outcomes Research Network, as well as the All of Us Research Initiative. Listen to the podcast to hear Deven discuss: what HIPAA is and what it was created to do how HIPAA guarantees people access to their health information tips for requesting and then keeping track of your medical records Running time: 22:39Learn more about Ciitizen.Thank you for listening to the Breastcancer.org podcast. Please subscribe on iTunes, Stitch

Kimberly Irvine is a two-time breast cancer survivor, passionate advocate, consultant, and CEO of her Chicago firm at kimberlyirvine.com. Kim was first diagnosed with breast cancer when she was 31 years old; her second diagnosis came four years later at age 35. Her treatments included surgeries, chemotherapy, and radiation, all while being a mother to two young children. Currently, she has no evidence of disease. Kim attributes her survivorship to her faith, strength, hope, and passion. She has recently published a memoir about her breast cancer experience titled STRONG(ER+): Becoming My Own Best Advocate and Discovering My Purpose. By sharing her story as a two-time cancer survivor, Kim aims to empower others to be advocates in their healthcare decisions.Listen to the podcast to hear Kim discuss: what it means to be your own advocate how being an advocate gives you some control over situations you may feel you have no control over 10 steps you can take to help you be your own best advocate Running time: 21

Ashish Khanna, M.D., is a physical medicine and rehabilitation specialist at the Kessler Institute for Rehabilitation and part of the ReVital Cancer Rehabilitation Program. Dr. Khanna completed his residency in physical medicine and rehabilitation at the Kingsbrook Jewish Rehabilitation Institute in Brooklyn, NY, where he became interested in cancer rehabilitation early on. He completed his fellowship subspecialization in cancer rehabilitation at Medstar Georgetown University/National Rehabilitation Hospital in Washington, DC. He specializes in the treatment of people who have pain or functional issues as a result of cancer or cancer treatments, including people who have been diagnosed with breast cancer. This includes pain, shoulder issues, fatigue, joint pain from aromatase inhibitors, and other issues. He has lectured at numerous international conferences, has published peer-reviewed research on a variety of related topics, and is the co-author of an upcoming book on cancer rehabilitation. Listen to the po

Mallori Thompson is manager of the Duke Cancer Patient Support Program at the Duke Cancer Institute. Mallori received her master’s degree in mental health counseling from North Carolina Central University. Her area of expertise is the psychosocial care of patients diagnosed with cancer and their families. Her research involves learning about how cancer affects people who’ve been diagnosed, as well as their family members and their relationships. Mallori leads a multidisciplinary team of clinicians and researchers, including medical family therapists, oncology recreation therapists, child life specialists, and psychologists, as well as people who coordinate volunteer services and self-image programs. Listen to the podcast to hear Mallori explain: how the needs and concerns of cancer caregivers are different from those of people diagnosed with cancer the services that caregivers seem to use the most her top three suggestions for a caregiver who’s feeling overwhelmed or burned out Running time: 15:48Thank you

Dr. Chirag Shah is a radiation oncologist and director of clinical research for the department of radiation oncology at the Cleveland Clinic. Dr. Shah received his bachelor's degree from Youngstown State University and his medical degree from Northeast Ohio Medical University. He completed his internship and residency at William Beaumont Hospital from 2007 to 2012 and joined the Cleveland Clinic Staff in 2015. Dr. Shah serves as a reviewer for various medical journals and is a member of various medical societies. His primary research interests are breast cancer, sarcoma, prostate cancer, lymphoma, and innovative radiation treatment schedules as well as lymphedema. He has participated in numerous clinical trials. In this podcast, Dr. Shah talks about specific characteristics of early-stage breast cancer that make the cancer more likely to come back, which doctors call recurrence. Listen to the podcast to hear Dr. Shah discuss: the difference between local/regional recurrence and metastatic/distant recurrence

Vicki Flannery wears a number of hats: She’s a nurse in the Kansas City area; she’s a yoga instructor at weBuild4Life, a nonprofit that focuses on functional fitness and nutritional programs for cancer survivors and people with chronic illnesses; and she is a breast cancer survivor. Vicki’s yoga classes center around recovery, flexibility, and strengthening. Listen to the podcast to hear Vicki talk about: what yoga is and examples of different types of yoga the benefits yoga can offer to people who’ve been diagnosed with breast cancer precautions people who’ve been diagnosed with breast cancer may want to consider how she modified her own yoga practice after being diagnosed with breast cancer Running time: 29:58Thank you for listening to the Breastcancer.org podcast. Please subscribe on iTunes, Stitcher, Spotify, TuneIn, or wherever you listen to podcasts. To share your thoughts about this or any episode, leave feedback on the podcast episode landing page on our website.

Jennifer Litton, associate professor of breast Medical Oncology at the University of Texas MD Anderson Cancer Center, discusses the results of the EMBRACA study she presented at the 2017 San Antonio Breast Cancer Symposium showing that talazoparib, an experimental targeted therapy medicine, improved the time until the cancer grew in women with a BRCA1 or BRCA2 mutation who had been diagnosed with metastatic HER2-negative breast cancer compared to chemotherapy. Listen to the podcast to hear Dr. Litton explain: how talazoparib works whether talazoparib will offer benefits to women with other mutations linked to a higher risk of breast cancer how the side effects differed between talazoparib and chemotherapy why quality of life was better in women who were treated with talazoparib Running time: 9:58Editor's Note: Talzenna (chemical name: talazoparib) was approved by the U.S. Food and Drug Administration on Oct. 16, 2018, for the treatment of metastatic breast cancer in women with BRCA mutations. Learn more abou

Dr. Terry Mamounas is medical director of the comprehensive breast program at Orlando Health UF Health Cancer Center and is considered one of the country’s top cancer doctors. At the 2019 San Antonio Breast Cancer Symposium, he presented the latest results from a study looking at whether an additional 5 years of Femara after five years of a combination of tamoxifen and an aromatase inhibitor or 5 years of only an aromatase inhibitor offers benefits to postmenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer. Listen to the podcast to hear Dr. Mamounas discuss: the results showing additional Femara reduced the risk of distant recurrence – the breast cancer coming back in a part of the body away from the breast the amount of improvement in event-free survival side effects associated with taking Femara for another 5 years how he’s talking to his patients about these latest results Running time: 18:32 Thank you for listening to the Breastcancer.org podcast. Please subscribe

Dr. Madeleine Tilanus-Linthorst is a member of the department of surgery at the Erasmus University Medical Center in the Netherlands. At the 2019 San Antonio Breast Cancer Symposium, she presented research comparing breast cancer screening with MRI versus mammography in women at high risk of the disease because of strong family history. The results found that MRI found cancers earlier, when they were smaller in size and could potentially change screening standards in the Netherlands and other European countries. Listen to the podcast to hear Dr. Tilanus-Linthorst explain: differences in screening recommendations between the United States and the Netherlands why it’s important to find cancers earlier the risk of more false-positives with MRI screening Running time: 11:06 Thank you for listening to the Breastcancer.org podcast. Please subscribe on iTunes, Stitcher, Spotify, TuneIn, or wherever you listen to podcasts. To share your thoughts about this or any episode, leave feedback on the podcast episode

Dr. Brian Wojciechowski, Breastcancer.org’s medical adviser, specializes in the care of patients with cancer. He practices medical oncology in Delaware County, Pennsylvania at Riddle, Taylor, and Crozer Hospitals. His research has been presented at the San Antonio Breast Cancer Symposium, the world's largest scientific meeting on breast cancer. Listen to the podcast to hear Dr. Wojciechowski explain: the breast cancer treatments that may cause diarrhea why some people may be more prone to experiencing diarrhea treatments for diarrhea why it’s important to always report diarrhea to your doctor Running time: 12:27

Dr. Jack Cuzick is director of the Wolfson Institute of Preventive Medicine and head of the Center for Cancer Prevention at the Queen Mary University of London, where he holds the title of John Snow Professor of Epidemiology. He is internationally known for his research showing tamoxifen can be used to treat estrogen-receptor-positive breast cancer, as well as his work to help develop the Tyrer-Cuzick breast cancer risk evaluation tool, which helps women and their doctors estimate a woman’s risk of developing breast cancer. At the 2019 San Antonio Breast Cancer Symposium, he presented the latest results from the International Breast Cancer Intervention Study II Prevention Trial, looking at whether 5 years of Arimidex (chemical name: anastrozole) can reduce breast cancer risk in postmenopausal women who have higher-than-average risk of the disease but have not been diagnosed. Listen to the podcast to hear Dr. Cuzick discuss: how much Arimidex reduced risk after about 11 years of follow up why Arimidex is

Dr. Luca Gianni, president of the Fondazione Michelangelo in Milan, discusses the results of the NeoTRIP trial, which looked to see if adding the immunotherapy medicine Tecentriq (chemical name: atezolizumab) to chemotherapy before surgery for triple-negative breast cancer with a high risk of recurrence could improve the time women lived without the cancer coming back. Running time: 7:17 Thank you for listening to the Breastcancer.org podcast. Please subscribe on iTunes, Stitcher, Spotify, TuneIn, or wherever you listen to podcasts. To share your thoughts about this or any episode, leave feedback on the podcast episode landing page on our website.